Results of mutation analysis in patients with a greater than 2-fold rise in BCR-ABL and those with stable or decreasing levels
Consecutive BCR-ABL values in 214 patients . | No. patients (%) . | Mutation analysis (%) . | Acquired resistance (%) . |
|---|---|---|---|
| Rise of more than 2-fold | 56 of 214 (26) | ||
| Mutations | 34 of 56 (61) | 31 of 34 (91) | |
| No mutations | 22 of 56 (39) | 13 of 22 (59) | |
| Stable or decreasing levels | 158 of 214 (74) | ||
| Mutations | 1 of 158 (0.6) | 1 of 1 (100) | |
| No mutations | 157 of 158 (99) | 1 of 158 (0.6) |
Consecutive BCR-ABL values in 214 patients . | No. patients (%) . | Mutation analysis (%) . | Acquired resistance (%) . |
|---|---|---|---|
| Rise of more than 2-fold | 56 of 214 (26) | ||
| Mutations | 34 of 56 (61) | 31 of 34 (91) | |
| No mutations | 22 of 56 (39) | 13 of 22 (59) | |
| Stable or decreasing levels | 158 of 214 (74) | ||
| Mutations | 1 of 158 (0.6) | 1 of 1 (100) | |
| No mutations | 157 of 158 (99) | 1 of 158 (0.6) |